| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |